Delivery Order SPE2DB20D1051-SPE2DB25FD9CC
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors, with a contract ceiling value of $1,118.76. This non-set-aside delivery order was awarded on August 19, 2025, with an ultimate completion date of August 20, 2025, and is priced on a firm fixed-price basis. The product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug Corp maintains its corporate headquarters....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,554.79 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injector units. This firm fixed-price contract, awarded on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through open competition with no set-aside designation....
- The Defense Logistics Agency awarded a delivery order valued at $2,271.97 to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This competitive award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a firm fixed price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors valued at $2,652.22. This competitively awarded, firm fixed-price delivery order will be fulfilled from the contractor's Conshohocken, Pennsylvania facility, with an ultimate completion date of August 8, 2025. The award represents a routine pharmaceutical supply transaction under a non-set-aside...
- The Defense Logistics Agency awarded a $2,412.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract, with an ultimate completion date of July 25, 2025, was awarded on July 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a small-value transaction within...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. The contract has a ceiling value of $1,183.24 and an ultimate completion date of October 21, 2024. It is a firm fixed-price delivery order contract, and no set-aside was used. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $2,422.85 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This firm fixed-price contract, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,914.29 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This competitive, firm fixed-price delivery order is scheduled for completion by August 6, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a single procurement action under the company's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,236.18 on August 19, 2025, for the supply of Sumatriptan 6 mg/0.5 mL auto-injectors. This firm fixed price contract, which is not set-aside, will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of August 20, 2025. The delivery order represents a single transaction within AmerisourceBergen's broader federal pharmaceutical supply portfolio and supports the Defense Health...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,927.88 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide Sumatriptan 6 mg/0.5 mL autoinjectors. The contract has an ultimate completion date of November 25, 2024 and was not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB25FD9CCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Sumatriptan 6 mg/0.5 mL auto-injector units valued at $1,129.39, with an ultimate completion date of August 20, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and is classified as a child contract, indicating it derives from a larger indefinite delivery contract (IDC) vehicle. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC functions as a global pharmaceutical support vehicle enabling the company to supply medications and medical supplies to military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates consistent capability in delivering pharmaceuticals across multiple therapeutic domains to support Defense Health Agency and other federal healthcare systems through competitively awarded mechanisms with flexible delivery order arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/19/25 |